Abstract
The use of specific immunotherapy as a cancer treatment has been revised in the last decade, especially in patients who no longer respond to conventional treatments. Based on the importance of dendritic cells in antitumor response, immunizations have been proposed combining these cells with tumors, called hybrid cell vaccines, with the purpose of better antigen presentation and induction …